Autopsy report · NCT03140176

Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.

“The study was terminated early due to the inability to recruit the planned number of patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 years 5 months before it stopped.
• 77 participants enrolled.
• Results were posted on the registry 2 years 4 months after it ended.

Vital statistics

Status

Terminated

Sponsor

Pfizer

Sponsor type

Industry

Conditions

Metastatic Renal Cell Carcinoma

Interventions

Sunitinib

Participants

77

Sites

8

Countries

Algeria, Egypt, Kuwait, Morocco

Trials that died the same way

• Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
  “The study was terminated due to difficulty in recruiting patients.” (89% match in meaning)
• Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection
  “The study was terminated because it is very difficult to recruit more patients.” (88% match in meaning)
• Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
  “This study was terminated due to inability to recruit sufficient patients.” (87% match in meaning)
• The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
  “Study terminated due to lack of eligible patients” (85% match in meaning)
• Alvimopan Use in Polytraumatized Patients
  “This study was terminated due to failure to enroll, a low volume of patients met criteria.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.